Clinical Trial Update: The Effect of Reloading Prasugrel in a Patient Who Has Already Received a Loading Dose (LD) of Clopidogrel [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating reloading prasugrel in patients who previously received a loading dose of clopidogrel in acute coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• PRASUGREL (prasugrel)

Snippet

Sponsor: Medstar Health Research Institute | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED